Convalescent Plasma Donor Vaccine Study An Observational Antibody Level Study.
NCT04954937 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2021-07-15
Summary
There is a need to understand antibody responses following SARS-COV-2 infection and subsequent vaccination.
Conditions
- Healthy
Sponsors & Collaborators
-
NHS Blood and Transplant
lead OTHER_GOV
Principal Investigators
-
Lise Estcourt, MB BChir, DPhil · NHS Blood and Transplant
Eligibility
- Min Age
- 17 Years
- Max Age
- 66 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-04-20
- Primary Completion
- 2021-10-20
- Completion
- 2022-04-20
Countries
- United Kingdom
Study Locations
More Related Trials
-
Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection
NCT04456413 ·Status: TERMINATED ·Phase: PHASE2
-
Acquiring Convalescent Specimens for COVID-19 Antibodies
NCT04342195 ·Status: COMPLETED
-
Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19
NCT04405492 ·Status: UNKNOWN ·Phase: NA
-
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
NCT04376034 ·Status: RECRUITING ·Phase: PHASE3
-
SARS-CoV-2 Nucleic Acid Detection Kit Clinical Performance Study
NCT05492227 ·Status: COMPLETED
-
COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2
NCT05196932 ·Status: COMPLETED
-
Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection
NCT05669261 ·Status: UNKNOWN ·Phase: PHASE1
-
Dried Blood Spots for SARS-CoV-2 Serology (COVID-19).
NCT04880122 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Immunity Assessment
NCT05080231 ·Status: COMPLETED
-
Complement 2: Blood Donations to Develop Vaccines Against Infectious Diseases
NCT01945307 ·Status: COMPLETED
-
Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers
NCT04334876 ·Status: COMPLETED ·Phase: NA
-
Detection of Covid-19 in Tissue Samples of Orthopedic Origin
NCT04916561 ·Status: COMPLETED
-
Evaluation of Physiological Variables and Detection of Blood Loss Using the Zynex Fluid Monitoring System, Model CM-1600
NCT05463198 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Device That Separates Blood Cells From Serum/Plasma
NCT02853448 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating CfDNA/NETs in Subjects with Sepsis
NCT05647096 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings
NCT04352764 ·Status: UNKNOWN
-
A Normal Donor Sample Collection Study in Healthy Adults
NCT01318863 ·Status: COMPLETED
-
Clinical Evaluation of the CM-1500 During Apheresis Blood Donation
NCT05012462 ·Status: COMPLETED ·Phase: NA
-
Cellular-Mediated Immunity in COVID-19
NCT04746521 ·Status: UNKNOWN
-
Sysmex-XN 20 Analyser to Assess Lymphocyte Subsets and Other Haematological Parameters in Chronic/Acute Viral Infections
NCT03495570 ·Status: UNKNOWN
-
Collection and Distribution of Biospecimens for Novel Research Uses
NCT03848962 ·Status: RECRUITING
-
Collection of Human Biological Samples for the Development and Validation of New Methods of Diagnosis and for the Realization of Expertises Diagnostics in the Field of Infectious Diseases and Tropical
NCT03912246 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of Rapid Antibody Test for Covid-19
NCT05298462 ·Status: COMPLETED ·Phase: NA
-
Investigation of the Usability of Neutrocheck Amongst Healthy Volunteers and Healthcare Professionals.
NCT05852249 ·Status: UNKNOWN
-
Convalescent Plasma for the Treatment of Patients With COVID-19
NCT04372368 ·Status: NO_LONGER_AVAILABLE